Accueil   Diary - News   All news Erytech Pharma, positive results for GRASPA

Erytech Pharma, positive results for GRASPA

ERYTECH the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, announces the presentation of four case studies with GRASPA® in an expanded access program at the 56th Annual Meeting of the American Society of Hematology (ASH), December 6-9, 2014, in San Francisco, CA.


Read the press release